Search Results 421-430 of 108953 for b-

  1. Primary Mediastinal Large B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Primary mediastinal large B-cell lymphoma ... Biological therapies, such as lenalidomide, may stimulate or suppress the immune system in different ways and stop ...

  2. Publications - Bradley S. Schoch, M.D. - Mayo Clinic

    ... B, Gobbato B, Routman H, Parsons M, Roche CP. Initial clinical experience with a predictive clinical decision support tool for anatomic and reverse total ...

  3. Publications - William R. G. Perry, M.B., Ch.B., M.P.H. - Mayo Clinic

    B., M.P.H.. Request an Appointment · Overview · Publications. Publications. Print. Ferrari D, Peponis T, Violante T, Cheng JN, Perry WR, Larson DW, Behm KT.

  4. Patient Stories - Mei-Ean E. Yeow, B.M.B.S., B.M., B.Ch. - Mayo Clinic

    Mei-Ean E. Yeow, B.M.B.S., B.M., B.Ch. Request an Appointment.

  5. Publications - Moustafa M. El Khatib, M.B., B.Ch. - Mayo Clinic

    Moustafa M. El Khatib, M.B., B.Ch. Acute Care Surgeon; Critical Care Surgeon; General Surgeon; Trauma Surgeon.

  6. Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    It is not yet known whether standard combination chemotherapy is more effective than blinatumomab in treating relapsed B-cell acute lymphoblastic leukemia.

  7. Rosebud O. Roberts, M.B., Ch.B. - Mayo Clinic Faculty Profiles

    B., focuses on identifying risk factors for mild cognitive impairment (MCI) and dementia, both diseases of aging that affect memory and thinking skills. Dr.

  8. Riboflavin (oral route) - Side effects & dosage - Mayo Clinic

    Riboflavin (vitamin B 2) is needed to help break down carbohydrates, proteins, and fats. It also makes it possible for oxygen to be used by your body. Lack ...

  9. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR- ...

  10. Contact - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Contact the Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic about research on the genetic basis of chronic lymphocytic leukemia and ...